---------------------------------
QMB APPROVAL
---------------------------------
QMB Number: 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per form............14.90
---------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Hemasure Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
423504109
---------------------------------
(CUSIP Number)
Edwin H. Morgens, 10 East 50th Street, New York, NY 10022, (212) 705-0500
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
November 5, 1996
---------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|.
Check the following box if a fee is being paid with the statement [ ]. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 17 Pages
Exhibit Index Appears on Page 17
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 2 of 16 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Phoenix Partners
13-6272912
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
WC
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
New York State
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 179,000 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 179,000 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
179,000
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.2%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
PN
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 3 of 16 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Betje Partners
13-3118883
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
WC
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
New York State
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 61,600 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 61,600 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
61,600
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.8%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
PN
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 4 of 16 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Morgens Waterfall Vintiadis Investments N.V.
None
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
WC
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Netherlands Antilles
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 110,900 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 110,900 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
110,900
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.4%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
CO
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 5 of 16 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MWV Employee Retirement Plan Group Trust
13-3845507
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
WC
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
New York State
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 16,000 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 16,000 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,000
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.2%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
EP
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 6 of 16 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Phaeton International N.V.
None
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
AF
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Netherlands Antilles
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 0 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 0 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
110,900
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.4%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
CO
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 7 of 16 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Morgens, Waterfall, Vintiadis & Company, Inc.
13-2674766
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
AF
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
New York State
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 0 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 0 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
172,500
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.1%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
CO
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 8 of 16 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Edwin H. Morgens
###-##-####
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
AF
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 0 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 0 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
367,500
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.6%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
IN
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 423504109 Page 9 of 16 Pages
_________________________________________________________________
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Bruce Waterfall
###-##-####
_________________________________________________________________
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [x]
_________________________________________________________________
3) SEC USE ONLY
_________________________________________________________________
4) SOURCE OF FUNDS*
AF
_________________________________________________________________
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
_________________________________________________________________
6) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
_________________________________________________________________
NUMBER 7) SOLE VOTING POWER
OF 0 - See Response to Item 5
SHARES _______________________________________________
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
EACH _______________________________________________
REPORTING 9) SOLE DISPOSITIVE POWER
PERSON 0 - See Response to Item 5
WITH _______________________________________________
10) SHARED DISPOSITIVE POWER
0
_________________________________________________________________
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
351,500
_________________________________________________________________
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
_________________________________________________________________
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.4%
_________________________________________________________________
14) TYPE OF REPORTING PERSON*
IN
_________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Hemasure Inc. Page 10 of 16 Pages
Schedule 13D November 5, 1996
Item 1. Security and Issuer.
- ------- --------------------
This Amendment No. 1 ("Amendment") amends the statement on
Schedule 13D filed by the Reporting Persons (as defined below) with the
Commission on October 23, 1996 ("Statement") with respect to shares of common
stock, par value $.01 per share ("Common Stock"), of Hemasure Inc. (the
"Issuer"). The principal executive offices of the Issuer are located at 140
Locke Drive, Marlborough, Massachusetts 01752. This Amendment supplements and,
to the extent inconsistent therewith, amends the information set forth in the
Statement.
Item 2. Identity and Background.
- ------- ------------------------
This Statement is filed jointly by (a) Phoenix Partners
("Phoenix"), (b) Betje Partners ("Betje"), (c) Morgens Waterfall
Vintiadis Investments N.V. ("MWV"), (d) MWV Employee Retirement
Plan Group Trust ("MWV Plan"), (e) Phaeton International N.V.
("Phaeton"), (f) Morgens, Waterfall, Vintiadis & Company, Inc.
("Morgens Waterfall"), (g) Edwin H. Morgens ("Morgens") and (h)
Bruce Waterfall ("Waterfall" and together with the persons listed
in paragraphs (a) through (h), the "Reporting Persons").
MWV is a subsidiary of Phaeton. Phaeton is a controlling person
of MWV by virtue of its ownership of 100% of the outstanding shares of MWV.
Phaeton and MWV are Netherlands Antilles limited liability companies having
their principal offices at 6 John B. Gorsiraweg, Willemstad, Curacao,
Netherlands Antilles. The principal business of MWV is to invest in securities
of United States issuers. Phaeton is a holding company which invests in MWV and
companies with similar objectives.
The sole Managing Director of Phaeton and MWV is Offshore
Management Company N.V. ("Offshore"), a Netherlands Antilles limited liability
company having its principal office at 6 John B. Gorsiraweg, Willemstad,
Curacao, Netherlands Antilles. The principal business of Offshore is to act as
Managing Director of corporations domiciled in the Netherlands Antilles, and in
that capacity to provide local management, administrative, clerical and
accounting services similar to those which it provides to Phaeton and MWV.
Phaeton and MWV do not have any officers other than Offshore.
Phaeton and MWV have the following Board of Directors:
Name Address
---- -------
Halvor Astrup Fearnley Group A/S
35-38 Portman Square
London W1HOEU, England
<PAGE>
Hemasure Inc. Page 11 of 16 Pages
Schedule 13D November 5, 1996
Dr. M. Colyer Crum Harvard Business School
Cambridge, Massachusetts
Bassam Aburdene Capital Trust Ltd.
49 Mount Street
London WIY5RE, England
Fred Arthur Rank Packard Center 45
45 London Wall
London EC2, England
Mr. Astrup, a citizen of Norway, is Vice Chairman of Fearnley
Group and Chairman of Fearnley Finance Ltd., companies principally engaged in
project development in the international shipping industry.
Dr. Crum, a U.S. citizen, is a professor at the Harvard
Business School, where he holds the James R. Williston Chair of
Investment Management.
Mr. Aburdene, a U.S. citizen, is a Managing Partner of
Capital Trust Limited, a London-based financial services company
which is jointly owned by United States and Middle Eastern
institutions and investors.
Mr. Packard, a British citizen, is a partner of Banco de
Investimentos Garantia, a leading Brazilian investment bank.
Phoenix and Betje are New York limited partnerships having their
principal address at 10 East 50th Street, New York, New York 10022. The
principal business of Phoenix and Betje is to invest in securities of United
States issuers. Morgens and Waterfall are the managing members of MW Management
LLC, which is the general partner of Phoenix. All of the information concerning
Morgens and Waterfall is set forth below. Mr. Zanvyl Krieger is the general
partner of Betje. The business address of Mr. Krieger is c/o Weinberg and Green,
100 South Charles Street, Baltimore, Maryland 21201. Mr. Krieger's principal
occupation is a private investor.
MWV Plan is a trust established in 1994 for the benefit of the
employees of Morgens Waterfall. The trustees of the MWV Plan are David Ericson,
Dan Levinson, Morgens, John Raphael and Stephan Yost, all of whom are employees
of Morgens Waterfall. MWV Plan's principal address is 10 East 50th Street, New
York, New York 10022. All of the relevant information concerning Morgens
Waterfall and Morgens is set forth below.
Morgens Waterfall is a New York corporation having its principal
address at 10 East 50th Street, New York, New York 10022. The business of
Morgens Waterfall is rendering of financial services and as such it provides
discretionary investment advisory services pursuant to contracts with MWV and
Betje. Under the rules
<PAGE>
Hemasure Inc. Page 12 of 16 Pages
Schedule 13D November 6, 1996
promulgated by the Securities and Exchange Commission, Morgens Waterfall and its
principals may be considered "beneficial owners" of securities acquired by MWV
and Betje as a result of its advisory relationship to MWV and Betje.
Morgens is the Chairman of the Board of Directors and the
Secretary of Morgens Waterfall. Waterfall is the President and Assistant
Secretary of Morgens Waterfall and is also a Director. The primary occupations
of Morgens and Waterfall are to act as the principals in the business of Morgens
Waterfall. The business address of Morgens and Waterfall, each of whom is a
United States citizen, is at the office of Morgens Waterfall at 10 East 50th
Street, New York, New York 10022. Morgens Waterfall has no other officers and
directors.
During the past five years, none of the persons described in this
Item 2 have been convicted in a criminal proceeding. None of such persons is,
and during the past five years none has been, subject to a judgment, decree or
final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws, or finding any
violations with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration.
- ------- --------------------------------------------------
The Common Stock held by the Reporting Persons was sold in the
over-the-counter market through brokerage transactions.
Item 4. Purpose of Transaction.
- ------- -----------------------
The Common Stock was sold by Phoenix, Betje, MWV and MWV Plan in
the over-the-counter market through brokerage transactions in the ordinary
course of business. The Reporting Persons have no present plans or proposals
that relate to or would result in any of the actions enumerated in Item 4 of
Schedule 13D, although they reserve the right to buy additional securities of
the Issuer or sell securities of the Issuer from time to time.
Item 5. Interest in Securities of the Issuer.
- ------- -------------------------------------
(a) and (b) The following is the amount of Common Stock that is
beneficially owned by each Reporting Person:
Aggregate Percentage
Name # of Shares of Class
---- ----------- --------
Phoenix 179,000 2.2
Betje 61,600 0.8
MWV 110,900 1.4
MWV Plan 16,000 0.2
------- ----
Total 367,500 4.6
<PAGE>
Hemasure Inc. Page 13 of 16 Pages
Schedule 13D November 5, 1996
Phaeton does not directly own any of the Common Stock. Phaeton
may be deemed to indirectly beneficially own 110,900 shares of Common Stock by
virtue of its 100% ownership of MWV.
Morgens Waterfall does not directly own any of the Common Stock.
Morgens Waterfall may be deemed to indirectly beneficially own 172,500 shares of
Common Stock by virtue of contracts with MWV (110,900 shares) and Betje (61,600
shares) pursuant to which Morgens Waterfall provides discretionary investment
advisory services.
Morgens does not directly own any of the Common Stock. Morgens
may be deemed to indirectly beneficially own 367,500 shares of Common Stock by
virtue of his positions as Chairman of the Board of Directors and Secretary of
Morgens Waterfall (172,500 shares); as a managing member of MW Management LLC,
which is the general partner of Phoenix (179,000 shares); and as trustee of MWV
Plan (16,000 shares).
Waterfall does not directly own any of the Common Stock.
Waterfall may be deemed to indirectly beneficially own 351,500 shares of Common
Stock by virtue of his positions as President, Assistant Secretary and a
Director of Morgens Waterfall (172,500 shares) and as a managing member of MW
Management LLC, which is the general partner of Phoenix (179,000 shares).
Each Reporting Person hereby disclaims that it has any beneficial
interest in the securities owned, directly or indirectly, by any other entity.
The following is a list of all transactions involving the Common
Stock since the most recent filing on Schedule 13D by any of the Reporting
Persons:
No. of Price/
Name Date Shares Sold Share
- ---- ---- ----------- -----
Phoenix 11/05/96 32,900 sold $8.625
Betje 11/05/96 11,900 sold $8.625
MWV 11/05/96 20,200 sold $8.625
MWV Plan 11/05/96 5,000 sold $8.625
(d) Except as set forth above, no other person is known to have
the right to receive or the power to direct the receipt of dividends from, or
the proceeds from the sale of, the Common Stock.
<PAGE>
Hemasure Inc. Page 14 of 16 Pages
Schedule 13D November 5, 1996
(e) On November 5, 1996, the Reporting Persons ceased to be the
beneficial owners of more than five percent of the Common Stock of the Issuer.
Item 6. Contracts, Arrangements, Understandings or Relationships with
- ------- Respect to the Securities of the Issuer.
-------------------------------------------------------------
Except to the extent described in Items 2 and 5, none of the
persons identified in Item 2 is a party to any contract, arrangement,
understanding or relationship with respect to any securities of the Issuer.
Item 7. Material to be Filed as Exhibits.
- ------- ---------------------------------
EXHIBIT A Power of Attorney, dated December 15, 1993 granted to
Messrs. Morgens and Waterfall by the following parties:
Mr. Bruce Waterfall; Phoenix Partners; Morgens Waterfall
Income Partners; Betje Partners; Phaeton International
N.V.; Morgens, Waterfall, Vintiadis Investments N.V.; The
Common Fund for Non-Profit Organizations; Morgens
Waterfall Vintiadis & Company, Inc.; Restart Partners,
L.P.; Restart Partners II, L.P.; Restart Partners III,
L.P.; Restart Partners IV, L.P.; Morgens Waterfall,
Vintiadis & Co., Inc. Employees' Profit Sharing Plan; and
Mr. Edwin Morgens, for the specific purpose of executing
on their behalf any Schedule 13Ds and amendments thereto
for filing with the Securities and Exchange Commission
pursuant to the requirements of Rule 13d-1(f)
(incorporated by reference to Exhibit A of Amendment No.
2 to Schedule 13D filed on December 22, 1993 by Phoenix
Partners; Betje Partners; Phaeton International N.V.;
Morgens, Waterfall, Vintiadis Investments N.V.; Morgens
Waterfall Vintiadis & Company, Inc.; Edwin H. Morgens;
and Bruce Waterfall with respect to the common stock, par
value $.01 per share, of Sudbury, Inc.).
EXHIBIT B Power of Attorney, dated as of June 20, 1994 granted to
Messrs. Morgens and Waterfall by Morgens Waterfall
Overseas Partners, for the specific purpose of executing
on its behalf any Schedule 13Ds and amendments thereto
for filing with the Securities and Exchange Commission
pursuant to the requirements of Rule 13d-1(f)
(incorporated by reference to Exhibit B of Schedule 13D
filed on June 23, 1994 by Morgens Waterfall Overseas
Partners; Morgens Waterfall Income Partners; Morgens
Waterfall, Vintiadis & Co., Inc.; Restart Partners, L.P.;
Restart Partners II, L.P.; Restart Partners III, L.P.;
Restart Partners IV, L.P.; Morgens Waterfall, Vintiadis
& Co., Inc. Employees' Profit Sharing Plan; The Common
Fund for Non-Profit Organizations; Edwin H. Morgens; and
Bruce Waterfall with respect to the common stock, par
value $1.00 per share, of Best Products Co., Inc.).
<PAGE>
Hemasure Inc. Page 15 of 16 Pages
Schedule 13D November 5, 1996
SIGNATURES
After reasonable inquiry and to the best knowledge and belief
of each of the Reporting Persons, each such person or entity certifies that the
information set forth in this statement is true, complete and correct and agrees
that this statement is filed on behalf of each of them.
The Reporting Persons listed herein
Dated: October 23, 1996 By: /s/ Bruce Waterfall
--------------------------------
Bruce Waterfall, as attorney-in-
fact for each of the Reporting
Persons
<PAGE>
Hemasure Inc. Page 16 of 16 Pages
Schedule 13D November __, 1996
EXHIBIT INDEX
Page No.
---------
Exhibit A Power of Attorney Incorporated by
Reference
Exhibit B Power of Attorney Incorporated by
Reference
<PAGE>